Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A2 | O15244 | 1/20 | 0.54 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.54 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | CHAT | P28329 | 2/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 8/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7032473 | 0.84 | SLC22A2 (0.54) | SLC22A2SLC22A1SLC22A3SLC6A4LMNA | |
| SCHEMBL8987994 | 0.82 | SLC6A4 (0.46) | SLC22A2SLC22A1SLC22A3SLC6A4LMNA | |
| Phosphine SCHEMBL28136748 | 0.81 | ALDH1A1 (0.47) | LMNANPSR1TP53MAPTTHRB | |
| SCHEMBL11707018 | 0.78 | ALDH1A1 (0.50) | LMNANPSR1TP53MAPTTHRB | |
| Benzene SCHEMBL31091106 | 0.78 | ALDH1A1 (0.50) | LMNANPSR1TP53MAPTTHRB | |
| SCHEMBL143876 | 0.78 | ALDH1A1 (0.50) | LMNANPSR1TP53MAPTTHRB | |
| SCHEMBL8987913 | 0.78 | LMNA (0.38) | SLC22A2SLC22A1SLC22A3SLC6A4LMNA | |
| 1-Methylimidazole SCHEMBL11809067 | 0.76 | SLC22A2 (0.40) | SLC22A2SLC22A1SLC22A3SLC6A4LMNA | |
| Methylamine SCHEMBL30143867 | 0.75 | ALDH1A1 (0.41) | SLC22A2SLC22A1SLC22A3SLC6A4LMNA | |
| Methylamine SCHEMBL3628885 | 0.75 | ALDH1A1 (0.41) | SLC22A2SLC22A1SLC22A3SLC6A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 356 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0832136-B1 | POLYMER SUPPORTED CATALYST FOR OLEFIN POLYMERIZATION | EQUISTAR CHEM LP (US) | 2002-03-20 | — | — | EP | claimed |
| US-6169152-B1 | COPOLYMER OF ETHYLENE AND A POLAR GROUP-CONTAINING CYCLIC OLEFIN COMPRISING ESTER- OR ANHYDRIDE MODIFIED NORBORNENE OR PERHYDRO-2,3-DIDEHYDRO-1,4:5,8-DIMETHANONAPHTHALENE MADE WITH CATALYST SUCH AS 1,5,9-TRIAZACYCLODODECANYLTITANIUM CHLORIDE | JSR CORPORATION (JP) | 2001-01-02 | — | — | US | claimed |
| EP-0832136-A4 | POLYMER SUPPORTED CATALYST FOR OLEFIN POLYMERIZATION | QUANTUM CHEM CORP (US) | 1998-09-30 | — | — | EP | claimed |
| EP-0832136-A1 | POLYMER SUPPORTED CATALYST FOR OLEFIN POLYMERIZATION | QUANTUM CHEMICAL CORPORATION (US) | 1998-04-01 | — | — | EP | claimed |
| US-5587439-A | COORDINATION CATALYSTS | QUANTUM CHEMICAL CORPORATION (US) | 1996-12-24 | — | — | US | claimed |
| WO-1996035726-A1 | POLYMER SUPPORTED CATALYST FOR OLEFIN POLYMERIZATION | QUANTUM CHEMICAL CORPORATION (US) | 1996-11-14 | — | — | WO | claimed |
| US-5444134-A | Using a coordination catalyst | IDEMITSU KOSAN CO., LTD. (JP) | 1995-08-22 | — | — | US | claimed |
| US-20240308936-A1 | METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-09-19 | — | — | US | disclosed |
| EP-4385972-A1 | METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION | Idemitsu Kosan Co.,Ltd. (JP) | 2024-06-19 | — | — | EP | disclosed |
| WO-2024116789-A1 | LUBRICATING OIL COMPOSITION | 出光興産株式会社 | 2024-06-06 | — | — | WO | disclosed |
| EP-3626869-B1 | CRIMPED FIBERS AND NONWOVEN CLOTH | IDEMITSU KOSAN CO (JP) | 2024-04-24 | — | — | EP | disclosed |
| WO-2024080214-A1 | METHOD FOR PRODUCING α-OLEFIN POLYMER | 出光興産株式会社 | 2024-04-18 | — | — | WO | disclosed |
| US-20230235202-A1 | PLASTICIZER FOR RESINS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-07-27 | — | — | US | disclosed |
| EP-0572003-A2 | Process for producing an ethylenic polymer composition | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-12-01 | — | — | EP | disclosed |
| EP-0570931-A2 | Styrenic polymer, process for producing same and multi-layer material comprising same | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-11-24 | — | — | EP | disclosed |
| EP-0570932-A2 | Styrenic block copolymer and process for producing same | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-11-24 | — | — | EP | disclosed |
| EP-0559108-A1 | Graft copolymer, process for production thereof and resin composition containing same | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-09-08 | — | — | EP | disclosed |
| EP-0522581-A1 | Process for producing olefin based polymers and olefin polymerization catalyst | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-01-13 | — | — | EP | disclosed |
| EP-0513380-A1 | PROCESS FOR PRODUCING OLEFINIC POLYMER | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-11-19 | — | — | EP | disclosed |
| EP-0504418-A1 | PROCESS FOR PRODUCING CYCLOOLEFIN POLYMER, CYCLOOLEFIN COPOLYMER, AND COMPOSITION AND MOLDING PREPARED THEREFROM | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240308936-A1 | METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION | OXER1, AMY1A, MACF1 | SLC22A2 4038/4885SLC22A1 3933/4885SLC22A3 4482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.